Evofem Biosciences, Inc. (EVFM) Q2 2021 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Evofem Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.109 -- 00:00:05.853 Good afternoon, and welcome to EvoFem's Biosciences second quarter 2021 00:00:05.853 -- 00:00:09.996 results call. At this time, all participants are in listen-only mode. 00:00:09.996 -- 00:00:12.357 After the speaker's presentation, 00:00:12.357 -- 00:00:14.919 there will be a question-and-answer session. 00:00:14.919 -- 00:00:19.862 To ask a question during this session, you'll need to press star 1 on your telephone. 00:00:19.862 -- 00:00:22.544 Please be advised that today's conference is being recorded. 00:00:22.544 -- 00:00:27.587 I would now like to turn the call over to EvoFem's Vice President 00:00:27.587 -- 00:00:31.456 of Investor Relations, Amy Raskoff. 00:00:31.957 -- 00:00:35.979 Thank you, and good afternoon, everyone. If you haven't done so already, I encourage 00:00:35.979 -- 00:00:39.321 you to access the second quarter of 2021 presentation 00:00:39.321 -- 00:00:43.702 and the press release we issued earlier today, both of which are at evofem.com under 00:00:43.702 -- 00:00:48.100 the Investors tab. Before we begin, I would like to remind you that remarks on this call 00:00:48.100 -- 00:00:51.533 will contain forward-looking statements, which are made only as of today, August 11, 00:00:51.533 -- 00:00:56.567 2021. For a more detailed description of important risk factors that could cause 00:00:56.567 -- 00:01:01.792 our actual results to differ materially, please refer to our annual report on Form 10-K 00:01:01.792 -- 00:01:06.596 and our most recent file, 10-Q. With that, I'll turn the call over to Sandra Pelletier, 00:01:06.596 -- 00:01:12.057 EvoFem's CEO. Thank you, Amy, and thanks, everyone, for joining us today. 00:01:12.057 -- 00:01:15.779 FFM delivered strong and sustainable growth in the second quarter of ...